Paul Newbold

Janssen (United States) — United States

Medicine · Health Sciences

39h-index8.8kcitations151works4.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Asthma and respiratory diseases(66), Chronic Obstructive Pulmonary Disease (COPD) Research(41), Pediatric health and respiratory diseases(18), Respiratory and Cough-Related Research(16), Eosinophilic Esophagitis(12)

Publications151 total

POS1079 Pharmacodynamic Response of JNJ-77242113 in Serum and Skin of Patients with Moderate-to-Severe Psoriasis: 1-Year Results from FRONTIER 1 & 2
Annals of the Rheumatic Diseases·2025Open Access
Multivariate Cluster Analyses to Characterize Asthma Heterogeneity and Benralizumab Responsiveness
The Journal of Allergy and Clinical Immunology In Practice·2024· 9 citedOpen Access
Clinical Implications of Longitudinal Blood Eosinophil Counts in Patients With Severe Asthma
The Journal of Allergy and Clinical Immunology In Practice·2023· 17 citedOpen Access
The commutability of enzyme linked immunosorbent assays for the quantification of serum eosinophil-derived neurotoxin (EDN)
Journal of Immunological Methods·2021· 3 cited
Novel mechanisms of action contributing to benralizumab's potent anti-eosinophilic activity
European Respiratory Journal·2021· 55 citedOpen Access
Longitudinal Blood Eosinophil Counts and Eosinophilic Immune Dysfunction Among Placebo Patients with Severe Asthma from Phase 3 Benralizumab Studies
2021Open Access
Blood Eosinophil Count and Fractional Exhaled Nitric Oxide as a Combined Predictor of Treatment Response to Benralizumab for Patients with Severe, Eosinophilic Asthma
Pneumologie·2021· 1 cited
Eosinophil-derived neurotoxin: A biologically and analytically attractive asthma biomarker
PLoS ONE·2021· 37 citedOpen Access
The Effect of Benralizumab On Allergen-Induced Responses In Subjects With Mild Allergic Asthma
Journal of Allergy and Clinical Immunology·2021· 6 cited
The relationship between airway immunoglobulin activity and eosinophils in COPD
Journal of Cellular and Molecular Medicine·2020· 32 citedOpen Access
Type 2 inflammation in eosinophilic chronic obstructive pulmonary disease
Allergy·2020· 72 citedOpen Access
BLOOD EOSINOPHIL COUNT AND FRACTIONAL EXHALED NITRIC OXIDE AS A COMBINED PREDICTOR OF TREATMENT RESPONSE TO BENRALIZUMAB FOR PATIENTS WITH SEVERE, EOSINOPHILIC ASTHMA
CHEST Journal·2020· 2 citedOpen Access
Distinct Sputum Microbiome Profiles Before and After Benralizumab Therapy in Eosinophilic Chronic Obstructive Pulmonary Disease
2020
Association of Baseline Blood Eosinophil Counts and Serum IgE Concentrations on Exacerbations and Benralizumab Efficacy for Patients with Severe, Uncontrolled Asthma
Pneumologie·2020
Baseline Predictors of Being Exacerbation-Free During 2 Years of Benralizumab Treatment
Pneumologie·2020
Eosinophils, basophils and type 2 immune microenvironments in COPD-affected lung tissue
European Respiratory Journal·2020· 57 citedOpen Access
Influence of Key Clinical Baseline Characteristics on Benralizumab Response for Patients with Severe, Uncontrolled Asthma and Moderate Blood Eosinophilia
Journal of Allergy and Clinical Immunology·2020· 1 citedOpen Access
Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma
Advances in Therapy·2019· 69 citedOpen Access
S50 Association of baseline blood eosinophil counts and serum IgE concentrations on exacerbations and benralizumab efficacy for patients with severe, uncontrolled asthma
2019· 1 cited
P104 TOTAL NASAL SYMPTOM SCORE IMPROVEMENT WITH BENRALIZUMAB FOR PATIENTS WITH SEVERE, EOSINOPHILIC ASTHMA
Annals of Allergy Asthma & Immunology·2019· 2 cited
page 1 of 8Next →

Frequent Co-authors

Christopher E. Brightling(8), Mona Bafadhel(7), Paul Rugman(7), Mitchell Goldman(7), Tuyet‐Hang Pham(7), Ian Pavord(6), Dave Singh(6), Ian Hirsch(5), Koirobi Haldar(4), Michael R. Barer(4), Roland Kolbeck(4), Gautam Damera(4), Tatiana Kebadze(3), P M Dodson(3), Martin Jenkins(3), Sebastian L. Johnston(3), James Zangrilli(3), Michael A. Ghebre(3), Sarah Diver(3), Dhananjay Desai(3)